Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Molecular Imaging of Coronary Plaque Vulnerability Using 18F-fluorocholine PET-MRI in Patients With Coronary Artery Disease

NCT03252990 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT03252990
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03252990 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Molecular Imaging of Coronary Plaque Vulnerability Using 18F-fluorocholine PET-MRI in Patients With Coronary Artery Disease
Lead sponsor
Maastricht University Medical Center
Phase
Observational
Overall status
Completed
Start date
March 2, 2018
Completion date
December 6, 2019
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, coronary artery disease, coronary stenosis, heart attack, multi vessel coronary artery disease, myocardial infarction, myocardial ischemia